BRCA1alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

BRCA1alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy

Published:2017-03-07 Issue:5 Volume:56 Page:405-420
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Takada Mamoru¹²,Nagai Shigenori³,Haruta Masayuki¹,Sugino Ryuichi P.¹,Tozuka Katsunori⁴,Takei Hiroyuki⁴,Ohkubo Fumie³,Inoue Kenichi³,Kurosumi Masafumi⁵,Miyazaki Masaru²,Sato-Otsubo Aiko⁶,Sato Yusuke⁶,Ogawa Seishi⁶,Kaneko Yasuhiko¹^ORCID

Affiliation:

1. Research Institute for Clinical Oncology, Saitama Cancer Center; Saitama Japan

2. Department of General Surgery, Graduate School of Medicine; Chiba University; Chiba Japan

3. Divisions of Breast Oncology; Saitama Cancer Center; Saitama Japan

4. Divisions of Breast Surgery; Saitama Cancer Center; Ina Saitama Japan

5. Department of Pathology; Saitama Cancer Center; Saitama Japan

6. Division of Tumor Biology, Department of Pathology; Kyoto University School of Medicine; Kyoto Japan

Funder

Ministry of Health, Labour and Welfare, Japan

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference46 articles.

1. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance;Bouwman;Nat Rev Cancer,2012

2. Hallmarks of 'BRCAness' in sporadic cancers;Turner;Nat Rev Cancer,2004

3. BRCA1 and BRCA2: different roles in a common pathway of genome protection;Roy;Nat Rev Cancer,2012

4. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins;Prakash;Cold Spring Harb Perspect Biol,2015

5. BRCAness revisited;Lord;Nat Rev Cancer,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Predictive Biomarkers in Familial Breast Cancer;Cancers;2023-02-20

2. Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors;Frontiers in Oncology;2022-06-17

3. PTIP-Associated Protein 1: More Than a Component of the MLL3/4 Complex;Frontiers in Genetics;2022-06-09

4. X-box binding protein 1 (XBP1): a potential role in chemotherapy response, clinical pathologic features, non-inflamed tumour microenvironment for breast cancer;Bioscience Reports;2022-06

5. Patent survey on chemosensitizers (2015–2019);pH-Interfering Agents as Chemosensitizers in Cancer Therapy;2021